Targeting the Lung Using siRNA and Antisense Based Oligonucleotides

被引:15
|
作者
Moschos, Sterghios A. [2 ]
Spinks, Karen [2 ]
Williams, Andrew E. [3 ]
Lindsay, Mark A. [1 ,3 ]
机构
[1] Univ Manchester, Wythenshawe Hosp, Sch Translat Med, Resp Res Grp, Manchester M23 9LT, Lancs, England
[2] Pfizer Global Res & Dev, Sandwich CT13 9NU, Kent, England
[3] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Biopharmaceut Res Grp, London SW3 6LY, England
基金
英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
siRNA; antisense; airways; lung; RNA interference;
D O I
10.2174/138161208786898851
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The accessibility to topical administration through inhalation, combined with its large surface area, has led to speculation that the lung might offer an ideal target for the application of oligonucleotide based therapeutics. In this review, we shall critically examine the challenges facing antisense and siRNA based approaches for target validation in vivo and as potential therapeutics. In particular, we shall discuss the antisense and siRNA based approaches in relation to factors such as delivery, distribution, stability, off-target effects, unwanted immune responses and the selection of the optimum mRNA targets.
引用
收藏
页码:3620 / 3627
页数:8
相关论文
共 50 条
  • [1] Polymersome delivery of siRNA and antisense oligonucleotides
    Kim, Younghoon
    Tewari, Manorama
    Pajerowski, J. David
    Cai, Shenshen
    Sen, Shamik
    Williams, Jason
    Sirsi, Shashank
    Lutz, Gordon
    Discher, Dennis E.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2009, 134 (02) : 132 - 140
  • [2] Oral delivery of siRNA and antisense oligonucleotides
    Akhtar, Saghir
    [J]. JOURNAL OF DRUG TARGETING, 2009, 17 (07) : 491 - 495
  • [3] Polymersome delivery of siRNA and antisense oligonucleotides
    Discher, Dennis E.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [4] AEI 85-Targeting and delivery of siRNA or antisense oligonucleotides using nanoparticles fabricated via the PRINT process
    Canelas, Dorian A.
    Gao, Xin
    Tian, Shaomin
    Sazani, Peter L.
    Kole, Ryszard
    DeSimone, Joseph
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [5] Antisense Oligonucleotides Targeting Lipoprotein(a)
    Langsted, Anne
    Nordestgaard, Borge G.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2019, 21 (08)
  • [6] Antisense Oligonucleotides Targeting Lipoprotein(a)
    Anne Langsted
    Børge G. Nordestgaard
    [J]. Current Atherosclerosis Reports, 2019, 21
  • [7] Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
    Juliano, R.
    Bauman, J.
    Kang, H.
    Ming, X.
    [J]. MOLECULAR PHARMACEUTICS, 2009, 6 (03) : 686 - 695
  • [8] Antisense oligonucleotides in lung cancer
    Pujol, JL
    Jacot, W
    [J]. TUMORI, 2002, : S50 - S51
  • [9] Targeting TGF Signaling to Address Fibrosis Using Antisense Oligonucleotides
    March, James T.
    Golshirazi, Golnoush
    Cernisova, Viktorija
    Carr, Heidi
    Leong, Yee
    Ngoc Lu-Nguyen
    Popplewell, Linda J.
    [J]. BIOMEDICINES, 2018, 6 (03)
  • [10] Targeting neurodegenerative disease with antisense oligonucleotides
    Miller, TM
    Smith, RA
    Yamanaka, K
    Monia, B
    Condon, T
    Lobsiger, C
    Ward, C
    McAlonis-Downes, M
    Wei, HB
    Wancewicz, EV
    Hung, G
    Bennett, CF
    Cleveland, DW
    [J]. NEUROLOGY, 2006, 66 (05) : A131 - A131